Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mareike Verbeek

Showing results (31-40 of 61) with videos related to

Pageof 7
Sort By:
Bone Marrow Transplantation|April 14, 2025
Teduglutide for treatment-refractory severe intestinal acute graft-versus-host disease - a multicenter surveyNiklas Brehm, Francesca Biavasco, Johannes Clausen, et al.
Diagnostics (Basel, Switzerland)|March 6, 2021
Comparison of Cytomegalovirus-Specific Immune Cell Response to Proteins versus Peptides Using an IFN-γ ELISpot Assay after Hematopoietic Stem Cell TransplantationEva Wagner-Drouet, Daniel Teschner, Christine Wolschke, et al.
Transplantation and Cellular Therapy|December 17, 2025
Pretransplant HMA and Venetoclax in AML patients - a Real-World Analysis from the Cooperative Transplant Study GroupChristina Rautenberg, Matthias Stelljes, Gesine Bug, et al.
ESMO Open|October 24, 2020
Haematopoietic stem cell transplantation in adult soft-tissue sarcoma: an analysis from the European Society for Blood and Marrow TransplantationChristoph E Heilig, Manuela Badoglio, Myriam Labopin, et al.
Bone Marrow Transplantation|May 2, 2022
Impact of conditioning regimen intensity on outcomes of second allogeneic hematopoietic cell transplantation for secondary acute myelogenous leukemiaArnon Nagler, Christophe Peczynski, Bhagirathbhai Dholaria, et al.
British Journal of Haematology|November 1, 2018
Phase I/II study on cytarabine and idarubicin combined with escalating doses of clofarabine in newly diagnosed patients with acute myeloid leukaemia and high risk for induction failure (AMLSG 17-10 CIARA trial)Jürgen Krauter, Walter Fiedler, Richard F Schlenk, et al.
Bone Marrow Transplantation|May 14, 2022
Comparison of fludarabine-melphalan and fludarabine-treosulfan as conditioning prior to allogeneic hematopoietic cell transplantation-a registry study on behalf of the EBMT Acute Leukemia Working PartyJesus Duque-Afonso, Jürgen Finke, Myriam Labopin, et al.
Bone Marrow Transplantation|October 7, 2022
Correction to: Impact of conditioning regimen intensity on outcomes of second allogeneic hematopoietic cell transplantation for secondary acute myelogenous leukemiaArnon Nagler, Christophe Peczynski, Bhagirathbhai Dholaria, et al.
Bone Marrow Transplantation|April 8, 2022
Augmented FLAMSA-Bu versus FluBu2 reduced-intensity conditioning in patients with active relapsed/refractory acute myeloid leukemia: an EBMT analysisEduardo Rodríguez-Arbolí, Myriam Labopin, Matthias Eder, et al.
Haematologica|May 14, 2016
Targeted positron emission tomography imaging of CXCR4 expression in patients with acute myeloid leukemiaPeter Herhaus, Stefan Habringer, Kathrin Philipp-Abbrederis, et al.
Pageof 7

Showing results (31-40 of 61) with videos related to

Sort By:
Pageof 7
Bone Marrow Transplantation|April 14, 2025
Teduglutide for treatment-refractory severe intestinal acute graft-versus-host disease - a multicenter surveyNiklas Brehm, Francesca Biavasco, Johannes Clausen, et al.
Diagnostics (Basel, Switzerland)|March 6, 2021
Comparison of Cytomegalovirus-Specific Immune Cell Response to Proteins versus Peptides Using an IFN-γ ELISpot Assay after Hematopoietic Stem Cell TransplantationEva Wagner-Drouet, Daniel Teschner, Christine Wolschke, et al.
Transplantation and Cellular Therapy|December 17, 2025
Pretransplant HMA and Venetoclax in AML patients - a Real-World Analysis from the Cooperative Transplant Study GroupChristina Rautenberg, Matthias Stelljes, Gesine Bug, et al.
ESMO Open|October 24, 2020
Haematopoietic stem cell transplantation in adult soft-tissue sarcoma: an analysis from the European Society for Blood and Marrow TransplantationChristoph E Heilig, Manuela Badoglio, Myriam Labopin, et al.
Bone Marrow Transplantation|May 2, 2022
Impact of conditioning regimen intensity on outcomes of second allogeneic hematopoietic cell transplantation for secondary acute myelogenous leukemiaArnon Nagler, Christophe Peczynski, Bhagirathbhai Dholaria, et al.
British Journal of Haematology|November 1, 2018
Phase I/II study on cytarabine and idarubicin combined with escalating doses of clofarabine in newly diagnosed patients with acute myeloid leukaemia and high risk for induction failure (AMLSG 17-10 CIARA trial)Jürgen Krauter, Walter Fiedler, Richard F Schlenk, et al.
Bone Marrow Transplantation|May 14, 2022
Comparison of fludarabine-melphalan and fludarabine-treosulfan as conditioning prior to allogeneic hematopoietic cell transplantation-a registry study on behalf of the EBMT Acute Leukemia Working PartyJesus Duque-Afonso, Jürgen Finke, Myriam Labopin, et al.
Bone Marrow Transplantation|October 7, 2022
Correction to: Impact of conditioning regimen intensity on outcomes of second allogeneic hematopoietic cell transplantation for secondary acute myelogenous leukemiaArnon Nagler, Christophe Peczynski, Bhagirathbhai Dholaria, et al.
Bone Marrow Transplantation|April 8, 2022
Augmented FLAMSA-Bu versus FluBu2 reduced-intensity conditioning in patients with active relapsed/refractory acute myeloid leukemia: an EBMT analysisEduardo Rodríguez-Arbolí, Myriam Labopin, Matthias Eder, et al.
Haematologica|May 14, 2016
Targeted positron emission tomography imaging of CXCR4 expression in patients with acute myeloid leukemiaPeter Herhaus, Stefan Habringer, Kathrin Philipp-Abbrederis, et al.
Pageof 7